小结
详细信息
- 甲状腺激素的产生
- 甲状腺激素结合蛋白
- 甲状腺功能测试的指标：总论
- 已知的甲状腺功能失调及先前的观点
- 妊娠期甲状腺功能障碍筛查
- 甲状腺功能检查 (TFT)
- 低TSH联合高FT4和/或FT3
- 低TSH联合低FT4和/或FT3
- 低TSH联合正常FT4和/或FT3
- 高TSH联合高FT4和/或FT3
- 高TSH联合低FT4和/或FT3
- 高TSH联合正常FT4和/或FT3
- 正常TSH联合低FT4和/或FT3
- 药物的影响
撰稿人
作者
Mae Sheikh-Ali, MD
Northeast Florida Endocrine & Diabetes Associates
Jacksonville
FL
利益声明
MS-A declares that she is a speaker for Novo Nordisk, AstraZeneca, Amgen, Merck, Eli Lilly, Abbott, AbbVie, MannKind, Valeritas, and Janssen. MS-A declares that none of these are related to this topic.
鸣谢
Dr Mae Sheikh-Ali would like to gratefully acknowledge Dr Harshit Shah, Dr Melanie Thomas, Dr Anna Szafran-Swietlik, Dr Sandra Mesliniene, Dr Emad Naem, and Dr Abdul-Razzak Alamir, previous contributors to this topic. HS, MT, AS-S, SM, EN, and A-RA declare that they have no competing interests.
同行评议者
Ronald Merrell, MD
Professor of Surgery
Virginia Commonwealth University
Richmond
VA
利益声明
RM declares that he has no competing interests.
Georg Hennemann, MD
Professor of Medicine and Endocrinology
Medical Center Spijkenisse
The Hague
The Netherlands
利益声明
Not disclosed.
Simon Pearce, MD
Professor of Endocrinology
Newcastle University
Endocrine Unit
Royal Victoria Infirmary
Newcastle upon Tyne
UK
利益声明
SP declares that he has no competing interests.
V.S. Schneider, MD
Clinical Associate Professor of Medicine
Uniformed Services University of the Health Sciences
Bethesda
MD
MA and Senior Medical Advisor
NASA Headquarters
Washington
DC
利益声明
VSS declares that he has no competing interests.
患者教育信息
Underactive thyroid
更多 患者教育信息
登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明